Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of addiction and related disorders. Their lead product candidate, AD04, is an investigational drug designed to treat alcohol use disorder. Utilizing a precision medicine approach, Adial aims to address the significant unmet need in addiction treatment with their personalized therapeutics.
Notification